Next Generation News and Research

RSS

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve and Transfemoral Delivery System.

20 Nov 2012

EMUC discusses current and future prospects in imaging for prostate cancer

At the 4th European Multidisciplinary Meeting on Urological Cancers (EMUC) held this weekend in Barcelona, Spain, specialists from radiology, urology, medical oncology and pathology said that new developments and research are already underway but benefits to patients would take some time due to the need for clinical trials, the high cost of funding research and the ability of cancer experts to efficiently take advantage of new insights and approaches, among other challenges.

19 Nov 2012

Compressus integrates M*Modal's Speech Understanding technology with MEDxConnect system

Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.

17 Nov 2012

New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting

New England Biolabs, Inc. launched their new NEBNext "Ultra" kits at the recent American Society for Human Genetics annual meeting.

From New England Biolabs 17 Nov 2012

New insights into how MSCs ‘traffic’ from the circulation into tissues

Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem is that when culture-expanded MSCs are injected into the circulation, they have trouble gaining access to the inflamed tissues-exactly where their help is needed.

16 Nov 2012

Pachytene piRNAs play an essential role in protecting post-meiotic germ cells

Passing one's genes on to the next generation is a mark of evolutionary success. So it makes sense that the body would work to ensure that the genes the next generation inherits are exact replicas of the originals.

16 Nov 2012

Courtagen, AGBL enter exclusive distribution agreement for clinical tests

Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and manage a number of genetically based disorders.

15 Nov 2012

Viewpoints: Voters want Medicare protected in 'grand bargain;' Increases in taxes can't cover the 'fiscal cliff'; Kids' health needs more attention

As the ranking member on the House Financial Services Subcommittee on Domestic Monetary Policy and Technology, let me simply state the hard truth. To avoid the fiscal cliff and to get our budget deficit and the national debt under control, we need to do three things simultaneously: cut spending, increase revenue and have the courage to put everything on the table in a responsible, bipartisan manner.

15 Nov 2012

LanPercept to focus on advanced techniques for studying language and perception

LanPercept, a new Marie Curie Initial Training Network funded through the 7th EU Framework Programme, will develop cutting edge techniques to understand vision-language mapping across the life-span in typically and atypically developing populations. New tools and training software will be tested to help disabled and elderly people negotiate the translation between vision and language.

15 Nov 2012

Ion AmpliSeq Community Panels from Life Technologies

Life Technologies Corporation today announced Ion AmpliSeq Community Panels, a community-driven solution to gene panel sequencing that leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.

7 Nov 2012

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.

7 Nov 2012

Keep momentum going to pursue innovation in contraceptive options

"It has been a banner year for media attention, political will and global resources on family planning and women's and girls' rights and empowerment," Ward Cates, president emeritus of FHI 360; Laneta Dorflinger, a scientist with FHI 360; and Kirsten Vogelsong, a senior program officer with the family planning division of the Bill & Melinda Gates Foundation, write in the Huffington Post "Global Motherhood" blog, noting the London Summit on Family Planning, World Contraception Day, and the inaugural International Day of the Girl Child.

6 Nov 2012

New insight on ability of certain PAH-derived lesions to evade DNA repair machinery

A person doesn't have to go far to find a polycyclic aromatic hydrocarbon (PAH). These carcinogen precursors are inhaled through automobiles exhaust during the morning commute, are present in a drag of cigarette smoke, and are part of any barbequed meal.

4 Nov 2012

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

3 Nov 2012

Physicists to bring to market new drug-discovery tool using genetic sequencing

Today physicists at Wake Forest University and NanoMedica, their biotechnology company partner, received a $700,000 grant from the National Institutes of Health to bring to market a new drug-discovery tool using next-generation genetic sequencing.

3 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

1 Nov 2012

Viscus Biologics to develop and commercialize NFB’s new tissue repair material

Viscus Biologics LLC, Cleveland, Ohio, has secured an 18-month option to conduct further research into the development and commercialisation of a new tissue repair material developed by the Network of Excellence for Functional Biomaterials (NFB) at National University of Ireland, Galway.

31 Oct 2012

Complix to accelerate development of CPABs against intracellular disease targets

Complix announces that it has been awarded a €1.9 million grant (approximately USD$2.4 million) from the Flanders government through IWT (Agency for Innovation by Science and Technology in Flanders).

30 Oct 2012

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.

30 Oct 2012

Next Generation News and Research

St. Jude Medical’s Portico transcatheter heart valve receives European CE Mark approval

EMUC discusses current and future prospects in imaging for prostate cancer

Compressus integrates M*Modal's Speech Understanding technology with MEDxConnect system

New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting

New insights into how MSCs ‘traffic’ from the circulation into tissues

Pachytene piRNAs play an essential role in protecting post-meiotic germ cells

Courtagen, AGBL enter exclusive distribution agreement for clinical tests

Viewpoints: Voters want Medicare protected in 'grand bargain;' Increases in taxes can't cover the 'fiscal cliff'; Kids' health needs more attention

LanPercept to focus on advanced techniques for studying language and perception

Ion AmpliSeq Community Panels from Life Technologies

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Keep momentum going to pursue innovation in contraceptive options

New insight on ability of certain PAH-derived lesions to evade DNA repair machinery

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Physicists to bring to market new drug-discovery tool using genetic sequencing

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Viscus Biologics to develop and commercialize NFB’s new tissue repair material

Complix to accelerate development of CPABs against intracellular disease targets

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News